Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
EZZ Life Science Holdings Ltd. ( (AU:EZZ) ) has issued an announcement.
EZZ Life Science Holdings has appointed Gary Liu as Non-Executive Chair of the board, effective immediately, bringing significant international experience in listed company leadership, capital markets, strategy and M&A, with a strong focus on Asia-Pacific markets. The move is intended to strengthen the company’s governance framework and board capability as it pursues its growth strategy and expands internationally, and will allow CEO Mark Qin, who had been Interim Chair, to concentrate solely on executive operations, reinforcing a clearer separation between board oversight and management responsibilities.
The most recent analyst rating on (AU:EZZ) stock is a Buy with a A$2.00 price target. To see the full list of analyst forecasts on EZZ Life Science Holdings Ltd. stock, see the AU:EZZ Stock Forecast page.
More about EZZ Life Science Holdings Ltd.
EZZ Life Science Holdings Limited (ASX: EZZ) operates in the life sciences sector, focusing on health and wellness products and growth across international, particularly Asia-Pacific, markets. The company is pursuing an expansion strategy that relies on strong governance and listed-market expertise to support its capital markets and strategic development activities.
Average Trading Volume: 72,460
Technical Sentiment Signal: Sell
Current Market Cap: A$92.44M
For an in-depth examination of EZZ stock, go to TipRanks’ Overview page.